Articles
Articles covering different aspects of downstream processing and manufacture of biotherapeutics
-
Read ArticleRemoval of Endotoxins - From Bench to Process Scale
-
Read ArticleRemoval of Isoagglutinins from IVIG and Plasma Using Affinity Chromatography
-
If you found this article useful, why not contact us to arrange a technical presentation?
Contact Us -
Read ArticleA Rapid Screening Toolbox for Product Polishing
-
Read ArticleEvolveD™ Infographic
An infographic on the highlights of our EvolveD™ column range.
-
Read ArticleMulti-Mode Mimetic Ligand™ Library Infographic
-
Read ArticleEndotoxin Removal Infographic
-
Read ArticleDetermination of Dynamic Binding Capacity for Chromatography Adsorbent
How to determine the dynamic binding capacity of a chromatography adsorbent.
-
Follow Astrea on LinkedIn and receive updates directly to your feed
Follow Now -
Read ArticlePerformance Testing of Packed Columns
-
Read ArticleRe-use, Cleaning and sanitization of IsoClear™ Affinity Adsorbents
A scale-down reuse study was performed on an automated chromatography workstation using a 2 mL IsoClear B™ column challenged with 50 CV of plasma per cycle.
-
Read ArticleQuality First!
At Astrea Bioseparations we put product quality first and have committed to become the first chromatography adsorbent manufacturer to achieve full GMP compliance!
-
Read ArticleScreening for Chromatography Adsorbent Selection and Optimisation for Downstream Processing of Biopharmaceuticals
This article reviews the past and current options for screening of chromatography adsorbents for downstream process development and the use of emergent mixed mode ligand adsorbents for improved adsorb
-
Read ArticleScaling up Production
Astrea Bioseparations has been manufacturing chromatography adsorbents on the Isle of Man since 1989. In this article we will update you on the expansion of our adsorbent manufacturing capacity.
-
Read ArticleLigand Discovery Projects
Our goal is to provide you with a fully validated bespoke chromatography adsorbent and all the associated process conditions for purification of your target biomolecule.
-
If you found this article useful, why not contact us to arrange a technical presentation?
Contact Us -
Read ArticleCapture and purification of Fab fragments from human polyclonal IgG papain digest using Fabsorbent™ F1P HF
In response to demand we have developed an affinity adsorbent for the capture and purification of antibody fragments.
-
Read ArticleIs it really cost effective to develop a custom affinity ligand as a capture step in your downstream process?
We offer an extensive range of off-the-shelf Bioseparation products for the recovery and purification of biologicals as well as purification services including bespoke custom designed chromatography.
-
Read ArticleEvolve™ Process Column: Customer Evaluation
-
Read ArticleThe Evolve™ Process Column in NIBRT
User friendly and ergonomic; performance is comparable to more expensive columns and the single use aspect compares well to lengthy cleaning cycles.
-
Read ArticleEndotoxin removal & β-D-Glucan Interference
EtoxiClear™ has been shown to provide >3.4 log clearance of endotoxin from Fab fragments from an E. coli cell lysate, as well as from proteins such as IgG and HSA.
-
Read ArticleEtoxiClear™: An novel affinity adsorbent for the efficient removal of endotoxin
A number of methods have been adopted for the removal of endotoxin based on adsorption, in particular ion-exchange chromatography.
-
Follow Astrea on LinkedIn and receive updates directly to your feed
Follow Now -
Read ArticleCapture and purification of human serum albumin from human source plasma using Mimetic Blue® SA HL P6XL
In this application note we describe how human serum albumin is captured and purified from human source plasma using Mimetic Blue® SA HL P6XL.
-
Loading More...
